Tag: 3Antigen
VBI Vaccines Announces European Commission Authorization for PreHevbri™, a 3-Antigen Vaccine Against Hepatitis B in Adults
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), an immunology-focused biopharmaceutical company pursuing potent disease prevention and treatment, today announced that the European Commission (EC) has granted marketing authorization for PreHevbri™ [vaccin…